Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Return on Equity (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Return on Equity for 4 consecutive years, with 1.09% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 45.0% to 1.09% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.09% through Dec 2025, up 45.0% year-over-year, with the annual reading at 1.22% for FY2025, 2.0% down from the prior year.
  • Return on Equity for Q4 2025 was 1.09% at Orchestra BioMed Holdings, up from 3.41% in the prior quarter.
  • The five-year high for Return on Equity was 0.47% in Q2 2023, with the low at 8.13% in Q2 2025.
  • Average Return on Equity over 4 years is 1.75%, with a median of 1.07% recorded in 2024.
  • Peak annual rise in Return on Equity hit 45bps in 2025, while the deepest fall reached -705bps in 2025.
  • Over 4 years, Return on Equity stood at 0.57% in 2022, then dropped by -17bps to 0.67% in 2023, then crashed by -130bps to 1.54% in 2024, then grew by 29bps to 1.09% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 1.09%, 3.41%, and 8.13% for Q4 2025, Q3 2025, and Q2 2025 respectively.